Vertex Pharmaceuticals Incorporated (VRTX) is a biotechnology company operating in the United States, Europe and other international markets. It trades on Nasdaq under the ticker \u201cVRTX\u201d and is in the Healthcare \u2013 Biotech sector.<\/p>\n
The weekly chart is described as bullish while price stays above the August 2025 low. A move above the November 2024 high is said to confirm a rally in wave (III).<\/p>\n
Wave ((I)) is placed at $306.08 in July 2020 and wave ((II)) at $176.36 in October 2021. From there, (I) of ((III)) ended at $519.88 in November 2024, and (II) ended at $362.50 in August 2025.<\/p>\n
Inside (I), the levels are: I $292.75, II $233.01, III $510.63, IV $447.70, V $519.88. Inside III, ((1)) $324.75, ((2)) $282.21, ((3)) $448.40, ((4)) $391.01, ((5)) $510.63.<\/p>\n
Wave (II) is labelled a double three: w $377.85 in December 2024, x $519.68 in March 2025, y $362.50 in August 2025. After that, ((1)) ended at $507.92, and ((2)) is mapped as a 3- or 7-swing pullback with $463.78 as a referenced high, while a break below the August 2025 low is presented as an alternative risk case.<\/p>\n
Given the current corrective phase in Vertex Pharmaceuticals, we see this as a period of strategic positioning rather than aggressive buying. The stock remains in a larger bullish trend, but the immediate path points towards a temporary dip to complete its pullback from the highs we saw late last year. This view is supported by the price action since the August 2025 low of $362.50, which remains our key level of support.<\/p>\n
Looking back, the stock’s run-up to nearly $520 in November 2024 was followed by predictable profit-taking. Recent data reinforces this short-term caution, as Q4 2025 earnings, while strong, were met with a 5% sell-off as guidance was perceived as conservative. Options market data from late February 2026 showed an increase in the put-to-call ratio from 0.6 to 0.9, suggesting traders are positioning for further downside before the next major rally.<\/p>\n
For the coming weeks, we anticipate a potential short-lived bounce, but this is likely a trap before another move lower. Traders could consider selling call credit spreads with strike prices above the $465 resistance level to capitalize on this expected failure. This strategy profits from both the price decline and time decay during this corrective period.<\/p>\n
The primary opportunity lies in anticipating the end of this entire corrective sequence. As the stock approaches its projected low, selling cash-secured puts with strike prices in the $380-$400 range could be an effective strategy. This allows traders to collect premium while waiting for a more attractive entry point for a long-term bullish position.<\/p>\n
We must watch the implied volatility, which has ticked up to around 35%, making option selling strategies more attractive. However, any break below the critical August 2025 low at $362.50 would invalidate this immediate bullish outlook and signal a deeper correction. In that scenario, holding protective puts would be essential for any existing long positions.<\/p>\n","protected":false},"excerpt":{"rendered":"
Vertex Pharmaceuticals (VRTX) shows bullish weekly trend above August 2025 low; break November 2024 high confirms wave (III).<\/p>\n","protected":false},"author":103,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[59],"tags":[],"class_list":["post-45389","post","type-post","status-publish","format-standard","hentry","category-live-updates"],"acf":{"acf_article_selection_author":null},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.vtmarkets.com\/en-ca\/wp-json\/wp\/v2\/posts\/45389","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vtmarkets.com\/en-ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vtmarkets.com\/en-ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vtmarkets.com\/en-ca\/wp-json\/wp\/v2\/users\/103"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vtmarkets.com\/en-ca\/wp-json\/wp\/v2\/comments?post=45389"}],"version-history":[{"count":0,"href":"https:\/\/www.vtmarkets.com\/en-ca\/wp-json\/wp\/v2\/posts\/45389\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.vtmarkets.com\/en-ca\/wp-json\/wp\/v2\/media?parent=45389"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vtmarkets.com\/en-ca\/wp-json\/wp\/v2\/categories?post=45389"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vtmarkets.com\/en-ca\/wp-json\/wp\/v2\/tags?post=45389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}